WHMIS (o-Anisidine)

Workplace Hazardous Materials Information System

WHMIS 2015 classification - Note to reader
Update: 2022-09-21

  • Acute toxicity - oral - Category 41 2
  • Carcinogenicity - Category 1B3
  • Specific target organ toxicity - single exposure - Category 22 4
  • Specific target organ toxicity - repeated exposure - Category 22 5

  • WHMIS 2015 pictogram : Exclamation mark

  • WHMIS 2015 pictogram : Health hazard

Danger

Harmful if swallowed (H302)
May cause cancer (H350)
May cause damage to organs (H371)
May cause damage to organs through prolonged or repeated exposure (H373)

Ingredient disclosure

References

  • ▲1.  Centre canadien d'hygiène et de sécurité au travail, CHEMINFO, Hamilton, Ont. : Canadian Centre for Occupational Health and Safety   http://ccinfoweb.ccohs.ca/cheminfo/search.html
  • ▲2.  Bureau européen des substances chimiques, European Union Risk Assessment Report: o-Anisidine. 32nd Priority List, Vol. 15. Luxembourg : Office for Official Publications of the European Communities. (2002).
  • ▲3.  IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Some aromatic amines and related compounds. IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 127. Lyon : International Agency for Research on Cancer. (2021).   http://monographs.iarc.fr/
    Volume127.pdf
  • ▲4.  ASHBY, J. et al., «THE NON-GENOTOXICITY TO RODENTS OF THE POTENT RODENT BLADDER CARCINOGENS O-ANISIDIEN AND P-CRESIDINE .» Mutation Research. Vol. 250, no. 1, p. 115-133. (1991). [AP-036824]
  • ▲5.  ECHA (European Chemicals Agency) , Information on Chemicals (REACH). Helsinki, Finland.  

    http://echa.europa.eu/information-on-chemicals/registered-substances
    ECHA CHEM (europa.eu)


The [number] refers to the Information SST database of the CNESST Documentation Center.